_version_ 1784572193087160320
author Plaks, Vicki
Rossi, John M.
Chou, Justin
Wang, Linghua
Poddar, Soumya
Han, Guangchun
Wang, Zixing
Kuang, Shao-Qing
Chu, Fuliang
Davis, Richard E.
Vega, Francisco
Bashir, Zahid
Jacobson, Caron A.
Locke, Frederick L.
Reagan, Patrick M.
Rodig, Scott J.
Lekakis, Lazaros J.
Flinn, Ian W.
Miklos, David B.
Bot, Adrian
Neelapu, Sattva S.
author_facet Plaks, Vicki
Rossi, John M.
Chou, Justin
Wang, Linghua
Poddar, Soumya
Han, Guangchun
Wang, Zixing
Kuang, Shao-Qing
Chu, Fuliang
Davis, Richard E.
Vega, Francisco
Bashir, Zahid
Jacobson, Caron A.
Locke, Frederick L.
Reagan, Patrick M.
Rodig, Scott J.
Lekakis, Lazaros J.
Flinn, Ian W.
Miklos, David B.
Bot, Adrian
Neelapu, Sattva S.
author_sort Plaks, Vicki
collection PubMed
description
format Online
Article
Text
id pubmed-8462361
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-84623612021-09-28 CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel Plaks, Vicki Rossi, John M. Chou, Justin Wang, Linghua Poddar, Soumya Han, Guangchun Wang, Zixing Kuang, Shao-Qing Chu, Fuliang Davis, Richard E. Vega, Francisco Bashir, Zahid Jacobson, Caron A. Locke, Frederick L. Reagan, Patrick M. Rodig, Scott J. Lekakis, Lazaros J. Flinn, Ian W. Miklos, David B. Bot, Adrian Neelapu, Sattva S. Blood Letter to Blood American Society of Hematology 2021-09-23 /pmc/articles/PMC8462361/ /pubmed/34041526 http://dx.doi.org/10.1182/blood.2021010930 Text en © 2021 by The American Society of Hematology This article is made available via the PMC Open Access Subset for unrestricted reuse and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Letter to Blood
Plaks, Vicki
Rossi, John M.
Chou, Justin
Wang, Linghua
Poddar, Soumya
Han, Guangchun
Wang, Zixing
Kuang, Shao-Qing
Chu, Fuliang
Davis, Richard E.
Vega, Francisco
Bashir, Zahid
Jacobson, Caron A.
Locke, Frederick L.
Reagan, Patrick M.
Rodig, Scott J.
Lekakis, Lazaros J.
Flinn, Ian W.
Miklos, David B.
Bot, Adrian
Neelapu, Sattva S.
CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel
title CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel
title_full CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel
title_fullStr CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel
title_full_unstemmed CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel
title_short CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel
title_sort cd19 target evasion as a mechanism of relapse in large b-cell lymphoma treated with axicabtagene ciloleucel
topic Letter to Blood
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462361/
https://www.ncbi.nlm.nih.gov/pubmed/34041526
http://dx.doi.org/10.1182/blood.2021010930
work_keys_str_mv AT plaksvicki cd19targetevasionasamechanismofrelapseinlargebcelllymphomatreatedwithaxicabtageneciloleucel
AT rossijohnm cd19targetevasionasamechanismofrelapseinlargebcelllymphomatreatedwithaxicabtageneciloleucel
AT choujustin cd19targetevasionasamechanismofrelapseinlargebcelllymphomatreatedwithaxicabtageneciloleucel
AT wanglinghua cd19targetevasionasamechanismofrelapseinlargebcelllymphomatreatedwithaxicabtageneciloleucel
AT poddarsoumya cd19targetevasionasamechanismofrelapseinlargebcelllymphomatreatedwithaxicabtageneciloleucel
AT hanguangchun cd19targetevasionasamechanismofrelapseinlargebcelllymphomatreatedwithaxicabtageneciloleucel
AT wangzixing cd19targetevasionasamechanismofrelapseinlargebcelllymphomatreatedwithaxicabtageneciloleucel
AT kuangshaoqing cd19targetevasionasamechanismofrelapseinlargebcelllymphomatreatedwithaxicabtageneciloleucel
AT chufuliang cd19targetevasionasamechanismofrelapseinlargebcelllymphomatreatedwithaxicabtageneciloleucel
AT davisricharde cd19targetevasionasamechanismofrelapseinlargebcelllymphomatreatedwithaxicabtageneciloleucel
AT vegafrancisco cd19targetevasionasamechanismofrelapseinlargebcelllymphomatreatedwithaxicabtageneciloleucel
AT bashirzahid cd19targetevasionasamechanismofrelapseinlargebcelllymphomatreatedwithaxicabtageneciloleucel
AT jacobsoncarona cd19targetevasionasamechanismofrelapseinlargebcelllymphomatreatedwithaxicabtageneciloleucel
AT lockefrederickl cd19targetevasionasamechanismofrelapseinlargebcelllymphomatreatedwithaxicabtageneciloleucel
AT reaganpatrickm cd19targetevasionasamechanismofrelapseinlargebcelllymphomatreatedwithaxicabtageneciloleucel
AT rodigscottj cd19targetevasionasamechanismofrelapseinlargebcelllymphomatreatedwithaxicabtageneciloleucel
AT lekakislazarosj cd19targetevasionasamechanismofrelapseinlargebcelllymphomatreatedwithaxicabtageneciloleucel
AT flinnianw cd19targetevasionasamechanismofrelapseinlargebcelllymphomatreatedwithaxicabtageneciloleucel
AT miklosdavidb cd19targetevasionasamechanismofrelapseinlargebcelllymphomatreatedwithaxicabtageneciloleucel
AT botadrian cd19targetevasionasamechanismofrelapseinlargebcelllymphomatreatedwithaxicabtageneciloleucel
AT neelapusattvas cd19targetevasionasamechanismofrelapseinlargebcelllymphomatreatedwithaxicabtageneciloleucel